Enzalutamide in Metastatic Prostate Cancer. Reply
N Engl J Med
.
2019 Oct 10;381(15):1494-1495.
doi: 10.1056/NEJMc1910553.
Authors
Ian D Davis
1
,
Martin R Stockler
2
,
Christopher J Sweeney
3
Affiliations
1
Monash University Eastern Health Clinical School, Melbourne, VIC, Australia ian.davis@monash.edu.
2
University of Sydney National Health and Medical Research Council Clinical Trials Centre, Sydney, NSW, Australia.
3
Dana-Farber Cancer Institute, Boston, MA.
PMID:
31597033
DOI:
10.1056/NEJMc1910553
No abstract available
Publication types
Letter
Comment
MeSH terms
Benzamides
Humans
Male
Nitriles
Phenylthiohydantoin* / analogs & derivatives
Prostatic Neoplasms, Castration-Resistant*
Substances
Benzamides
Nitriles
Phenylthiohydantoin
enzalutamide